Home / Fact sheets / Belgium / Colorectal qualitative data
Check also the following factsheets: Belgium, Breast, Cervical
Country fact sheet: Belgium
COLORECTAL CANCER SCREENING PROGRAMME
| Reporting year for qualitative data: | 2016 |
| Source of qualitative data: | Other (EU Report 2017) |
Organization of screening | |
| An individual/team/institution responsible to coordinate the programme: | Yes |
| Dedicated budget for screening programme: | Yes |
| Documented cancer screening policy: | Yes |
| Nature of documentation of the policy: | Recommendation |
| Year programme was initiated: | 2009 |
| Programme introduction was preceded by a pilot: | - |
| Screening tests provided free of charge: | Yes |
| Diagnostic tests provided free of charge: | Yes |
| Treatment services provided free of charge: | - |
Information system and data collection | |
| System that collects data: | Individual & Aggregated |
| • Identification of eligible population: | - |
| • Screening participation: | - |
| • Screening test results: | - |
| • Further assessment: | - |
| • Final pathology diagnosis: | - |
| • Cancer staging: | - |
| • Treatment: | - |
| The information system exists at national or sub-national level: | Individual: Unknown Aggregated: Unknown |
| The information system collects data outside the programme (opportunistic screening/private sector): | - |
| Cancer screening data is linked with population-based cancer registry (PBCR): | Yes |
Screening protocol | |
| A screening protocol or guideline: | - |
| Year of published/updated protocol: | - |
| Target age (min-max) and screening interval [months] for each test: | FIT (50-74 years / [24 months]) Colonoscopy (- years / [120 months]) |
Invitations for screening and further assessment | |
| Initiatives to create population awareness by the Health Ministry/Health Authority: | - |
| Invitations to eligible population: | Yes |
| Source of the eligible individuals identified: | |
| Method of invitation: | Letter |
| Screening kit included with the invitation: | Yes |
| Screen positive individuals actively contacted for further assessment: | No |
| Individuals with a precancer or cancer diagnosis actively contacted: | - |
Quality Assurance (QA) of screening activities | |
| Documented standard operating procedure/policy for QA: | Yes |
| An individual/team/institution responsible for QA: | Yes |
| Accreditation of endoscopy units: | - |
| Accreditation of pathology services: | - |
| Documented performance indicators: | Yes |
| Reference standards for performance indicators: | - |
| Evaluation reports published in the last five years: | Yes |
Performance indicators | |
| Reporting year for quantitative data: | 2016 |
| Source of quantitative data: | Report (EU Report 2017) |
| FIT | gFOBT | Sigmoidoscopy | Colonoscopy | |
| Target age and regional limitation if applicable: | 50-74 (Flanders) | 50-74 (Wallonia) | ||
| Invitation coverage (%): | 93.0 | 123.8 | ||
| Participation rate (%): | 50.3 | 4.5 | ||
| Examination coverage (%): | 46.7 | 5.6 | ||
| Completeness of data related to screening results (%): | 100.0 | 97.9 | ||
| Completeness of data related to information about attendance to colonoscopy assessment (%): | 100.0 | 100.1 | ||
| Further assessment (diagnosis colonoscopy) rate (%): | 8.1 | 3.9 | ||
| Further assessment participation rate (%): | 36.3 | 72.6 | ||
| Detection rate of adenomas (x 1000): | 6.8 | |||
| Detection rate of advanced adenomas (x 1000): | 4.75 | |||
| Detection rate of colorectal cancers (x 1000): | 2.0 | |||
| Positive Predictive Value of further assessment to detect adenomas (%): | 23.1 | |||
| Positive Predictive Value of further assessment to detect advanced adenomas (%): | 16.0 | |||
| Positive Predictive Value of further assessment to detect colorectal cancers (%): | 6.7 | |||
| More quantitative data (Flanders: Male - 2014/FIT) | ||||
| More quantitative data (Flanders: Women - 2014/FIT) | ||||
| More quantitative data (Wallonia: Male - 2014/gFOBT) | ||||
| More quantitative data (Wallonia: Women - 2014/gFOBT) |
Check also the following factsheets: Belgium, Breast, Cervical